AACR 2026: five days of multiplex IF in San Diego
1,400 conversations at booth 1042, two posters, and the first public run of the Connector workflow on a live tissue section. Here is what happened — and what we took home.
The question everyone brought to the booth
Almost every conversation started the same way: can I keep the antibodies I have already validated? For most groups, the panel is not the bottleneck — the revalidation work is. We spent the week showing the Connector workflow on tissue people brought with them, and watching the answer land.
By Sunday afternoon the demo station had run an 8-plex panel eleven times, and the questions had shifted from whether it works to how quickly a lab can be running it themselves.
What we presented
Two posters, both built on tissue from collaborating labs rather than in-house material — the point being that the workflow has to survive somebody else's fixation protocol.
Poster 5108 — Signal separation across eight markers without spectral unmixing artefacts. Wed 22 April, 9:00–12:30 · Section 18
Rapid and reliable mIF assay development for ADC profiling
A case study using Revolune Illuminate reagents — panel development, inter-operator consistency, and a clinical research example in bladder carcinoma.
“The best moment was a group bringing their own slide on day three — and leaving with an eight-marker image of it.”
The team that was there
Thanks to everyone who stopped by, brought a slide, or argued with us about marker order — and to the five who stood at the booth for five days.
Drug Discovery Strategic Summit
The Drug Discovery Strategic Summit (DDSS) is an invitation-only summit that empowers senior executives, pioneers, and stakeholders to forge impactful partnerships and share transformative initiatives. Experience a focused environment where strategic conversations drive real-world outcomes for the evolving drug discovery landscape.
Get an individual demo online
Twenty minutes with an application scientist, your tissue, your markers — remote and no charge.